Furthermore, in prostate cancer, βIII-tubulin expression is associated with both TMPRSS2:ERG rearrangement, ERG expression and PTEN deletions, three key oncogenetic features in metastatic prostate cancer [48]. The gene discussed is ERG; the disease is prostate carcinoma.